Cetrocare 0.25 mg Combi Pack Injection 1's
₹1657*
₹1408*
MRP ₹1657
15% CB
₹249 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Cetrocare 0.25 mg Combi Pack Injection 1's belongs to the class of drugs called hormones used to treat female infertility in women. Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg), and implantation (fertilized egg attaches to uterus lining).
If eggs are released too early during fertility treatment, they may not be suitable for fertilization. Cetrocare 0.25 mg Combi Pack Injection 1's contains Cetrorelix, an anti-gonadotropin-releasing hormone that works by blocking a natural hormone in the body. Thereby, it inhibits premature ovulation (the release of eggs from the ovary too early).
Take Cetrocare 0.25 mg Combi Pack Injection 1's as prescribed by your doctor. You are advised to take Cetrocare 0.25 mg Combi Pack Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience itching, redness, or swelling at the site of injection, headache, or nausea. Most of these side effects of Cetrocare 0.25 mg Combi Pack Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Cetrocare 0.25 mg Combi Pack Injection 1's or any other medicines, please tell your doctor. Avoid taking Cetrocare 0.25 mg Combi Pack Injection 1's if you are pregnant or breastfeeding, and consult a doctor before taking Cetrocare 0.25 mg Combi Pack Injection 1's. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of the ovarian hyper-stimulation syndrome (OHSS).
Cetrocare 0.25 mg Combi Pack Injection 1's contains Cetrorelix, a hormone that blocks a natural hormone in the body. Thereby, it inhibits premature ovulation (release of eggs from the ovary too early). If eggs are released too early during fertility treatment, they may not be suitable for fertilization.
If you are allergic to Cetrocare 0.25 mg Combi Pack Injection 1's or any other medicines, please tell your doctor. If you have any kidney or liver problems, inform your doctor before taking Cetrocare 0.25 mg Combi Pack Injection 1's. Avoid taking Cetrocare 0.25 mg Combi Pack Injection 1's if you are pregnant or breastfeeding, and consult a doctor before taking Cetrocare 0.25 mg Combi Pack Injection 1's. You are recommended to remove Cetrocare 0.25 mg Combi Pack Injection 1's from the refrigerator 30 minutes before using it. Wash your hands and inject Cetrocare 0.25 mg Combi Pack Injection 1's under the skin of the belly as instructed by your doctor. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of ovarian hyper-stimulation syndrome (OHSS).
Drug-Drug Interaction: Inform your doctor if you are taking any vitamins, OTC medicines, or herbal products.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have any kidney or liver problems, inform your doctor before taking Cetrocare 0.25 mg Combi Pack Injection 1's.
Female infertility: Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg), and implantation (fertilized egg attaches to uterus lining). The risk factors for infertility in females include smoking, heavy alcohol consumption, obesity, underweight, increasing age, or sexually transmitted infections. Also, certain medical conditions such as uterine fibroids, endometriosis, premature ovarian failure, polycystic ovary syndrome (PCOS), hormonal imbalances, scarring from previous surgery, or pelvic inflammatory disease may cause infertility in females.
Alcohol
Caution
The interaction of Cetrocare 0.25 mg Combi Pack Injection 1's with alcohol is unknown. Please consult a doctor before consuming alcohol while using Cetrocare 0.25 mg Combi Pack Injection 1's.
Pregnancy
Unsafe
Cetrocare 0.25 mg Combi Pack Injection 1's is a category X pregnancy drug and is not recommended for use during pregnancy as it may cause miscarriage, stillbirth, or birth defects. However, please consult a doctor if you are pregnant.
Breast Feeding
Unsafe
Cetrocare 0.25 mg Combi Pack Injection 1's is contraindicated in breastfeeding women. Please consult a doctor if you are breastfeeding.
Driving
Safe if prescribed
Cetrocare 0.25 mg Combi Pack Injection 1's usually does not affect your ability to drive or operate machinery.
Liver
Caution
If you have any concerns regarding the use of Cetrocare 0.25 mg Combi Pack Injection 1's in patients with Liver problems, please consult a doctor.
Kidney
Caution
If you have any concerns regarding using Cetrocare 0.25 mg Combi Pack Injection 1's in patients with kidney problems, please consult a doctor. Avoid using Cetrocare 0.25 mg Combi Pack Injection 1's if you have severe kidney disease.
Children
Unsafe
Cetrocare 0.25 mg Combi Pack Injection 1's is not recommended for children.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes